Solid Biosciences Inc.
SLDB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $582,557 | $458,463 | $245,463 | $163,268 |
| - Cash | $61,364 | $138,933 | $210,629 | $80,235 |
| + Debt | $21,937 | $23,051 | $23,626 | $24,177 |
| Enterprise Value | $543,130 | $342,581 | $58,460 | $107,210 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$386 | -$407 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$45,400 | -$39,034 | -$38,807 | -$42,034 |
| % Margin | – | – | – | – |
| Net Income | -$45,776 | -$39,480 | -$39,282 | -$42,597 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.48 | -0.42 | -0.59 | -0.8 |
| % Growth | -14.3% | 28.8% | 26.3% | – |
| Operating Cash Flow | -$33,472 | -$37,412 | -$31,850 | -$29,645 |
| Capital Expenditures | -$85 | -$377 | -$126 | -$204 |
| Free Cash Flow | -$33,557 | -$37,789 | -$31,976 | -$29,849 |